5,7-dihydroxytryptamine has been researched along with physostigmine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aihara, H; Hashimoto, S; Okuyama, S; Shimamura, H | 1 |
Ahlers, ST; Bragin, V; Davis, KL; Gluck, R; Gotlib, J; Haroutunian, V; Shea, PA; Sugar, J; Wallace, W | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and physostigmine
Article | Year |
---|---|
Relation between yawning behavior and central serotonergic neuronal system in rats.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Apomorphine; Corpus Striatum; Dose-Response Relationship, Drug; Fenclonine; Male; Microinjections; Physostigmine; Rats; Rats, Inbred Strains; Serotonin; Yawning | 1987 |
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Actins; Afferent Pathways; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Diabetes Mellitus, Experimental; Functional Laterality; Glucocorticoids; Kinetics; Lidocaine; Male; N-Methylaspartate; Norepinephrine; Oxidopamine; Physostigmine; Polyribosomes; Raphe Nuclei; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Innominata; Time Factors | 1993 |